On October 1, 2021 the CNS is proud to announce a new and improved user experience for all your SANS education needs. You’ll retain access to any current subscriptions
but answers on exams won’t transfer over - so make sure you complete any exams and claim credit by September 30 or start the new SANS 2021 today

  • Natural History of Familial Versus Non-familial Cavernous Malformation: Systematic Review and Meta-analysis

    Final Number:
    1081

    Authors:
    Shervin Taslimi; amirhossein modabbernia; Sepideh Amin-Hanjani MD, FAANS, FACS, FAHA; Frederick George Barker MD; R. Loch Macdonald MD, PhD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2016 Annual Meeting

    Introduction: Cavernous malformation can be divided into familial and non-familial cases. This systematic review is sought to investigate the natural history of cavernoma in familial and non-familial cases with more focus on aspects other than bleeding.

    Methods: We searched MEDLINE, Web of Science, and EMBASE for natural history studies on cavernous malformation until May 2015. We included studies that at least followed up 20 untreated patients (including pre-surgical follow up). Our primary outcomes were calculation and comparison of hemorrhage, seizure, and dynamic changes in familial and non-familial cases. Our secondary outcomes were comparison of familial with non-familial cases. Incidence rate per person year or lesion year of follow up were used to pool the data using fixed or random effect model. We used incidence rate ratio for comparison.

    Results: Based on inclusion of 6 studies and 251 individuals, seizure rate was similar in familial and non-familial cases with pooled incidence rate of 1.6%/PY (1.1%-2.3%).With inclusion of 6 studies and 322 individuals, re-seizure rate was higher than seizure rate (P<0.001). New lesion development was higher in familial cases (32.1% versus 0.7% per person year, P<0.001). Signal change ranged from 0.2% to 2.4% per LY in familial cases. In familial cases incidence rate of size change was 8% (5.2%-12.2%) and 1.1% (0.6%-1.6%) per PY and LY respectively.

    Conclusions: Cavernomas show dynamic changes in familial and non-familial cases. However, this is not certain for non-familial cases based on current evidence. Cavernomas demonstrate low incidence of seizure rate. However, more refinement of the incidence rate based on the location and type of the lesion should be investigated.

    Patient Care: It helps physician to have better understanding of the natural history of the cavernous malformation, specially in familial cases. This will affect their decision on treatment planning. Patients can be better informed of the nature of the disease and can make a better informed decision.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Describe the importance of follow up in cavernous malformation 2) Describe possible dynamic changes in cavernous malformation lesions 3) Discuss, in small groups incidence rate of the seizure and epilepsy in cavernous malformation and risk factors of that 4) Identify different symptoms of the cavernous malformation and incidence rate of them 5) discuss in small groups the gap in our knowledge regarding the natural history of cavernous malformation that necessitates further well designed future studies.

    References: No references

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy